Publicaciones en colaboración con investigadores/as de Hospital de Sabadell (19)

2023

  1. Significant Differences in IBD Care and Education across Europe: Results of the Pan-European VIPER Survey

    Digestive Diseases, Vol. 41, Núm. 3, pp. 387-395

2021

  1. Incidence, clinical characteristics and management of inflammatory bowel disease in spain: Large-scale epidemiological study

    Journal of Clinical Medicine, Vol. 10, Núm. 13

2020

  1. Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)

    Helicobacter, Vol. 25, Núm. 5

  2. Effectiveness and Safety of the Sequential Use of a Second and Third Anti-TNF Agent in Patients with Inflammatory Bowel Disease: Results from the Eneida Registry

    Inflammatory Bowel Diseases, Vol. 26, Núm. 4, pp. 606-616

  3. Predictive value of carcinoembryonic antigen in symptomatic patients without colorectal cancer: A post-hoc analysis within the colonpredict cohort

    Diagnostics, Vol. 10, Núm. 12

  4. Retrospective cohort study: Risk of gastrointestinal cancer in a symptomatic cohort after a complete colonoscopy: Role of faecal immunochemical test

    World Journal of Gastroenterology, Vol. 26, Núm. 1, pp. 70-85

2017

  1. Accuracy of the Ultra-Rapid Urease Test for diagnosis of Helicobacter pylori infection

    Gastroenterologia y Hepatologia, Vol. 40, Núm. 10, pp. 651-657

  2. Evolution after Anti-TNF Discontinuation in Patients with Inflammatory Bowel Disease: A Multicenter Long-Term Follow-Up Study

    American Journal of Gastroenterology, Vol. 112, Núm. 1, pp. 120-131

  3. The fecal hemoglobin concentration, age and sex test score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients

    International Journal of Cancer, Vol. 140, Núm. 10, pp. 2201-2211

2016

  1. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients

    BMC Medicine, Vol. 14, Núm. 1

  2. Diagnostic performance of the simple clinical colitis activity index self-administered online at home by patients with ulcerative colitis: CRONICA-UC study

    American Journal of Gastroenterology, Vol. 111, Núm. 2, pp. 261-268

2014

  1. Hemospray treatment is effective for lower gastrointestinal bleeding

    Endoscopy, Vol. 46, Núm. 1, pp. 75-78

2013

  1. Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome

    Journal of Crohn's and Colitis, Vol. 7, Núm. 9, pp. 717-722

2012

  1. Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failures

    Alimentary Pharmacology and Therapeutics, Vol. 35, Núm. 8, pp. 941-947

2011

  1. The changing face of hospitalisation due to gastrointestinal bleeding and perforation

    Alimentary Pharmacology and Therapeutics, Vol. 33, Núm. 5, pp. 585-591

2010

  1. Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: The RECLICU Study

    Journal of Crohn's and Colitis, Vol. 4, Núm. 6, pp. 629-636

2009

  1. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice

    American Journal of Gastroenterology, Vol. 104, Núm. 7, pp. 1633-1641

2008

  1. Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice

    American Journal of Gastroenterology, Vol. 103, Núm. 9, pp. 2220-2223

2005

  1. Seven versus ten days of rabeprazole triple therapy for Helicobacter pylori eradication: A multicenter randomized trial

    American Journal of Gastroenterology, Vol. 100, Núm. 8, pp. 1696-1701